Bone Mineral Density in Different Menopause Stages is Associated with Follicle Stimulating Hormone Levels in Healthy Women
Open Access
- 28 January 2021
- journal article
- research article
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 18 (3), 1200
- https://doi.org/10.3390/ijerph18031200
Abstract
Although estradiol (E2) has been believed to be the most critical factor in the menopause-associated decrease in bone mineral density (BMD), the role of increasing follicle stimulating hormone (FSH) during menopause is relatively unclear. We determined the extent to which hip and lumbar spine BMD differ among the stages of menopause in healthy women, and whether BMD is associated with FSH and E2 levels. A cross-sectional study of 141 healthy women classified as premenopausal (Pre; 38 ± 6 yrs; mean ± SD, n = 30), early perimenopausal (EPeri; 50 ± 3yrs, n = 31), late perimenopausal (LPeri; 50 ± 4yrs, n = 30), early postmenopausal (EPost; 55 ± 3yrs, n = 24), or late postmenopausal (LPost; 62 ± 4 yrs, n = 26), was conducted. Spine/hip BMD and sex hormones were measured using dual-energy X-ray absorptiometry and enzymatic/colorimetric methods, respectively. Compared to EPeri, spine BMD was lower (p < 0.05) in LPeri, EPost, and LPost and hip BMD was lower (p < 0.05) in EPost and LPost. BMD was inversely associated with FSH (spine: r = −0.341; hip: r = −0.271, p < 0.05) and directly associated with E2 (spine: r = 0.274; hip: r = 0.256, p < 0.05). The menopause-related loss of spine and hip BMD is associated not only with low E2 but also higher FSH. Future studies are essential to delineating the mechanisms by which FSH regulates bone health in aging women.Funding Information
- the National Research Foundation of Korea (2020R1F1A1056974, 2020S1A5A8043551)
This publication has 39 references indexed in Scilit:
- Blocking antibody to the β-subunit of FSH prevents bone loss by inhibiting bone resorption and stimulating bone synthesisProceedings of the National Academy of Sciences of the United States of America, 2012
- Tetrahydrobiopterin improves endothelial function and decreases arterial stiffness in estrogen-deficient postmenopausal womenAmerican Journal of Physiology-Heart and Circulatory Physiology, 2012
- Bone mineral density loss in relation to the final menstrual period in a multiethnic cohort: Results from the Study of Women's Health Across the Nation (SWAN)Journal of Bone and Mineral Research, 2011
- Amount of Bone Loss in Relation to Time around the Final Menstrual Period and Follicle-Stimulating Hormone Staging of the TransmenopauseJournal of Clinical Endocrinology & Metabolism, 2010
- Increased visceral fat and decreased energy expenditure during the menopausal transitionInternational Journal of Obesity, 2008
- Bone Mineral Density Changes during the Menopause Transition in a Multiethnic Cohort of WomenJournal of Clinical Endocrinology & Metabolism, 2008
- Changes in Body Composition in Women over Six Years at Midlife: Ovarian and Chronological AgingJournal of Clinical Endocrinology & Metabolism, 2007
- Estradiol and NorgestimateDrugs & Aging, 2001
- Hemostatic, Metabolic, and Androgenic Risk Factors for Coronary Heart Disease in Physically Active and Less Active Postmenopausal WomenArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Radial bone mineral density in pre- and perimenopausal women: A prospective study of rates and risk factors for lossJournal of Bone and Mineral Research, 1992